Literature DB >> 23354954

Mixed vaginitis-more than coinfection and with therapeutic implications.

Jack D Sobel1, Chitra Subramanian, Betsy Foxman, Marilyn Fairfax, Scott E Gygax.   

Abstract

Mixed vaginitis is due to the simultaneous presence of at least two vaginal pathogens, both contributing to an abnormal vaginal milieu and, hence, symptoms and signs of vaginitis. In mixed vaginitis, both pathogens require specific therapy for complete eradication of concurrent manifestations. In coinfection, although two pathogens are identified, a potential pathogen may be present but may not be a cause of existing vaginal symptoms. Although data remain sparse, mixed vaginitis occurs rarely (<5 %). By contrast, pathogen coinfection occurs frequently in women with vaginitis. Approximately 20 %-30 % of women with bacterial vaginosis (BV) are coinfected with Candida species. Coexistence of BV pathogens and T. vaginalis is even more common, with coinfection rates of 60 %-80 %. Both coinfection and mixed vaginitis have significant clinical and therapeutic implications and are worthy of further investigation.

Entities:  

Year:  2013        PMID: 23354954     DOI: 10.1007/s11908-013-0325-5

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  30 in total

1.  The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women.

Authors:  Megan Gatski; David H Martin; Judy Levison; Leandro Mena; Rebecca A Clark; Mary Murphy; Harold Henderson; Norine Schmidt; Patricia Kissinger
Journal:  Sex Transm Infect       Date:  2011-01-29       Impact factor: 3.519

2.  ["Mixed" and "miscellaneous" vulvovaginitis: diagnostics and therapy of vaginal administration of nystatin and nifuratel].

Authors:  P Cepický; J Malina; Z Líbalová; M Kuzelová
Journal:  Ceska Gynekol       Date:  2005-05

3.  The infrequent use of office-based diagnostic tests for vaginitis.

Authors:  H C Wiesenfeld; I Macio
Journal:  Am J Obstet Gynecol       Date:  1999-07       Impact factor: 8.661

4.  Advances in diagnosing vaginitis: development of a new algorithm.

Authors:  Paul Nyirjesy; Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

5.  Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection.

Authors:  Harold C Wiesenfeld; Sharon L Hillier; Marijane A Krohn; Daniel V Landers; Richard L Sweet
Journal:  Clin Infect Dis       Date:  2003-02-07       Impact factor: 9.079

6.  Office laboratory diagnosis of vaginitis. Clinician-performed tests compared with a rapid nucleic acid hybridization test.

Authors:  D G Ferris; J Hendrich; P M Payne; A Getts; R Rassekh; D Mathis; M S Litaker
Journal:  J Fam Pract       Date:  1995-12       Impact factor: 0.493

7.  Symptoms and signs in single and mixed genital infections.

Authors:  P A Mårdh; K Tchoudomirova; S Elshibly; D Hellberg
Journal:  Int J Gynaecol Obstet       Date:  1998-11       Impact factor: 3.561

8.  Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard.

Authors:  Nancy K Lowe; Jeremy L Neal; Nancy A Ryan-Wenger
Journal:  Obstet Gynecol       Date:  2009-01       Impact factor: 7.661

9.  Vulvovaginal candidiasis complicating recurrent bacterial vaginosis.

Authors:  V Redondo-Lopez; C Meriwether; C Schmitt; M Opitz; R Cook; J D Sobel
Journal:  Sex Transm Dis       Date:  1990 Jan-Mar       Impact factor: 2.830

10.  A universal combination treatment for vaginitis.

Authors:  Jacob Bornstein; Doron Zarfati
Journal:  Gynecol Obstet Invest       Date:  2006-12-04       Impact factor: 2.031

View more
  18 in total

1.  In Vitro Activity of Fenticonazole against Candida and Bacterial Vaginitis Isolates Determined by Mono- or Dual-Species Testing Assays.

Authors:  Maurizio Sanguinetti; Emilia Cantón; Riccardo Torelli; Fabio Tumietto; Ana Espinel-Ingroff; Brunella Posteraro
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

2.  A study on vaginitis among pregnant and non-pregnant females in Alexandria, Egypt: An unexpected high rate of mixed vaginal infection.

Authors:  Sherine Mohamed Shawaky; Mariam Majed Ali Al Shammari; Manal Shafik Sewelliam; Abeer Abd El Rahim Ghazal; Ahmed Noby Amer
Journal:  AIMS Microbiol       Date:  2022-05-05

3.  Accurate 16S Absolute Quantification Sequencing Revealed Vaginal Microecological Composition and Dynamics During Mixed Vaginitis Treatment With Fufang FuRong Effervescent Suppository.

Authors:  Meng Li; Zhen Zeng; Huijun Feng; Yang Cao; Qiongqiong Zhang; Tao Lv; Xingsheng Yang; Dianrong Song; Ping Li; Lina Hu; Shangrong Fan; Ruifang An; Bei Zhang; Lei Zhang; Qinping Liao
Journal:  Front Cell Infect Microbiol       Date:  2022-05-13       Impact factor: 6.073

4.  Brazilian Protocol for Sexually Transmitted Infections, 2020: infections causing vaginal discharge.

Authors:  Newton Sergio de Carvalho; José Eleutério Junior; Ana Gabriela Travassos; Lutigardes Bastos Santana; Angélica Espinosa Miranda
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

5.  Prevalence of bacterial vaginosis and associated risk factors in pregnant women receiving antenatal care at the Kumba Health District (KHD), Cameroon.

Authors:  Yiewou Marguerithe Kamga; John Palle Ngunde; Jane-Francis K T Akoachere
Journal:  BMC Pregnancy Childbirth       Date:  2019-05-10       Impact factor: 3.007

Review 6.  Immunopathology of Recurrent Vulvovaginal Infections: New Aspects and Research Directions.

Authors:  Namarta Kalia; Jatinder Singh; Manpreet Kaur
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

7.  Longitudinal analysis of vaginal microbiome dynamics in women with recurrent bacterial vaginosis: recognition of the conversion process.

Authors:  Janet A Lambert; Susan John; Jack D Sobel; Robert A Akins
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

Review 8.  Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis.

Authors:  Jack D Sobel
Journal:  Patient Prefer Adherence       Date:  2013-12-16       Impact factor: 2.711

Review 9.  Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review.

Authors:  Werner Mendling; Ernst Rainer Weissenbacher; Stefan Gerber; Valdas Prasauskas; Philipp Grob
Journal:  Arch Gynecol Obstet       Date:  2015-10-27       Impact factor: 2.344

10.  Diagnostic Performance of a Molecular Test versus Clinician Assessment of Vaginitis.

Authors:  Jane R Schwebke; Charlotte A Gaydos; Paul Nyirjesy; Sonia Paradis; Salma Kodsi; Charles K Cooper
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.